ORGANOGENESIS HOLDINGS INC. Gain (Loss) Related to Litigation Settlement
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Gain (Loss) Related to Litigation Settlement of $2.25 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2023-03-01
- ORGANOGENESIS HOLDINGS INC. gain (loss) related to litigation settlement for the quarter ending 2020-09-30 was $951.00K.
- ORGANOGENESIS HOLDINGS INC. gain (loss) related to litigation settlement for the quarter ending 2020-06-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. gain (loss) related to litigation settlement for the quarter ending 2020-03-31 was $1.29M.
- ORGANOGENESIS HOLDINGS INC. gain (loss) related to litigation settlement for fiscal 2020 was $2.25M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2020-12-31 | $2.25M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $951.00K 10-Q · filed 2021-11-09 | $951.00K derived: sum of 2 quarters · filed 2021-11-09 | $2.25M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.29M 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | $1.29M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |